1. Grünewald, Lena, Becker, Nils, Camphausen, Annika, Freudenberg, Florian, Reif, Andreas. 2018. Expression of the ADHD candidate gene Diras2 in the brain. In Journal of neural transmission (Vienna, Austria : 1996), 125, 913-923. doi:10.1007/s00702-018-1867-3. https://pubmed.ncbi.nlm.nih.gov/29488099/
2. Chang, Yu, Chen, Qian, Li, Hua, Xiong, Xiufang, Sun, Yi. 2024. The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells. In Developmental cell, 59, 1317-1332.e5. doi:10.1016/j.devcel.2024.03.018. https://pubmed.ncbi.nlm.nih.gov/38574733/
3. Reif, Andreas, Nguyen, T Trang, Weissflog, Lena, Franke, Barbara, Lesch, Klaus-Peter. 2011. DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 36, 2318-27. doi:10.1038/npp.2011.120. https://pubmed.ncbi.nlm.nih.gov/21750579/
4. Ying, Ke, Wang, Chan, Liu, Shuiping, Tao, Qian, Hu, Xiaotong. 2022. Diverse Ras-related GTPase DIRAS2, downregulated by PSMD2 in a proteasome-mediated way, inhibits colorectal cancer proliferation by blocking NF-κB signaling. In International journal of biological sciences, 18, 1039-1050. doi:10.7150/ijbs.68312. https://pubmed.ncbi.nlm.nih.gov/35173535/
5. Grünewald, Lena, Landaas, Elisabeth Toverud, Geissler, Julia, Binder, Elisabeth, Reif, Andreas. 2016. Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 41, 3025-3031. doi:10.1038/npp.2016.113. https://pubmed.ncbi.nlm.nih.gov/27364329/
智鼠故事 
